Tarsons Products Limited Receives Credit Rating Reaffirmation from CARE

1 min read     Updated on 01 Apr 2026, 02:09 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Tarsons Products Limited received credit rating reaffirmation from CARE for bank facilities totaling ₹612.73 crores. The rating agency maintained CARE A; Stable for long-term facilities and CARE A1 for short-term facilities. Notable changes include reduction in long-term facilities from ₹516.02 crores to ₹500.73 crores and enhancement of short-term facilities from ₹39.00 crores to ₹84.00 crores, along with assignment of new ₹4.00 crores short-term facilities.

powered bylight_fuzz_icon
36535192

*this image is generated using AI for illustrative purposes only.

Tarsons Products Limited has announced that CARE has reaffirmed the credit ratings for its bank loan facilities through a press release dated March 30, 2026. The company informed stock exchanges about this development on March 31, 2026, in compliance with SEBI listing regulations.

Credit Rating Details

CARE has maintained stable ratings across all facility categories for Tarsons Products. The rating reaffirmation covers total bank facilities worth ₹612.73 crores across different categories.

Facilities Amount (₹ crores) Rating Rating Action
Long Term Bank Facilities 500.73 (Reduced from 516.02) CARE A; Stable Reaffirmed
Long-Term/Short-Term Bank Facilities 24.00 (Reduced from 25.00) CARE A; Stable / CARE A1 Reaffirmed
Short-Term Bank Facilities 4.00 CARE A1 Assigned
Short-Term Bank Facilities 84.00 (Enhanced from 39.00) CARE A1 Reaffirmed

Facility Amount Changes

The rating reaffirmation came with notable changes in facility amounts. Long-term bank facilities were reduced from ₹516.02 crores to ₹500.73 crores, representing a decrease of ₹15.29 crores. Similarly, the long-term/short-term bank facilities saw a marginal reduction from ₹25.00 crores to ₹24.00 crores.

Conversely, short-term bank facilities were significantly enhanced from ₹39.00 crores to ₹84.00 crores, more than doubling the available facility amount. The company also received a new assignment of ₹4.00 crores in short-term bank facilities with a CARE A1 rating.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Santosh Kumar Agarwal, who serves as CFO, Company Secretary and Compliance Officer, signed the regulatory filing. The company has also made this information available on its website at www.tarsons.com for stakeholder reference.

Historical Stock Returns for Tarsons Products

1 Day5 Days1 Month6 Months1 Year5 Years
+8.06%+1.12%-5.72%-41.05%-49.22%-78.02%

What strategic initiatives might Tarsons Products pursue with the significantly increased short-term facility allocation of ₹84 crores?

How could the reduction in long-term facilities impact Tarsons' capital expenditure plans and expansion projects over the next 2-3 years?

Will the shift from long-term to short-term facilities affect Tarsons' working capital management and operational flexibility?

Tarsons Products Limited Issues Postal Ballot Notice for Independent Director Appointment

2 min read     Updated on 06 Mar 2026, 04:14 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Tarsons Products Limited has issued a postal ballot notice dated March 06, 2026, seeking shareholder approval for appointing Mr. Vinesh Mohan Kriplani (DIN: 08212644) as Non-Executive Independent Director for five consecutive years from February 06, 2026 to February 05, 2031. The remote e-voting period runs from March 07, 2026 at 09:00 A.M. to April 06, 2026 at 05:00 P.M. (IST), with results expected by April 08, 2026. Mr. Kriplani is a Chartered Accountant with 29 years of experience in corporate taxation and M&A, currently associated with Serum Institute of India.

powered bylight_fuzz_icon
34339445

*this image is generated using AI for illustrative purposes only.

Tarsons Products Limited has issued a postal ballot notice seeking shareholder approval for the appointment of Mr. Vinesh Mohan Kriplani as Non-Executive Independent Director. The notice, dated March 06, 2026, follows the company's earlier intimation to stock exchanges regarding the Board of Directors' decision to appoint Mr. Kriplani to the position.

Appointment Details and Timeline

The proposed appointment seeks to designate Mr. Vinesh Mohan Kriplani (DIN: 08212644) as Non-Executive Independent Director for a term of five consecutive years. The appointment period extends from February 06, 2026 to February 05, 2031, and the director will not be liable to retire by rotation.

Parameter: Details
Director Name: Mr. Vinesh Mohan Kriplani
DIN: 08212644
Position: Non-Executive Independent Director
Term Duration: Five consecutive years
Appointment Period: February 06, 2026 to February 05, 2031
Retirement by Rotation: Not applicable

E-Voting Process and Key Dates

The company has engaged National Securities Depository Limited (NSDL) to provide remote e-voting facility to shareholders. The voting process will be conducted exclusively through electronic mode, with no physical postal ballot forms being distributed to members.

Timeline Component: Date and Time
Cut-off Date: Friday, February 27, 2026
E-voting Commencement: Saturday, March 07, 2026 at 09:00 A.M. (IST)
E-voting Conclusion: Monday, April 06, 2026 at 05:00 P.M. (IST)
Results Declaration: On or before Wednesday, April 08, 2026
Scrutinizer: M/s. Manisha Saraf & Associates

Director Profile and Qualifications

Mr. Vinesh Mohan Kriplani brings extensive experience in corporate finance and taxation to the board. Born on November 21, 1972, he is a Chartered Accountant with over 29 years of experience in Indian corporate and international taxation, specializing in mergers and acquisitions, corporate restructuring, and cross-border transactions.

Currently associated with the Poonawalla Group through Serum Institute of India, Mr. Kriplani leads M&A and international tax matters, advising senior leadership on strategic growth initiatives. His expertise spans transfer pricing, tax dispute resolution, valuations, and foreign exchange regulations.

Professional Background

Mr. Kriplani has previously held senior leadership roles with Ernst & Young, KPMG, and PricewaterhouseCoopers, including serving as Senior Partner at EY India, where he built and led a market-leading tax practice. He has worked across India and Hong Kong, advising multinational clients on complex transactions. He is also a co-founder of Transaction Square LLP and has served at the Board level of a regulated NBFC.

Current Directorships and Committee Memberships

Mr. Kriplani currently serves as a director of Magma General Insurance Limited, where he holds memberships in key committees:

  • Audit Committee – Member
  • Investment Committee – Member

Regulatory Compliance and Documentation

The company has received all statutory disclosures and declarations from Mr. Kriplani, including consent to act as director, confirmation of independence criteria compliance, and various regulatory clearances. The Nomination and Remuneration Committee had previously finalized the desired attributes for Independent Director selection and recommended Mr. Kriplani's candidature based on his experience, expertise, and independence.

The postal ballot notice is available on the company's website at www.tarsons.com and on NSDL's website at www.evoting.nsdl.com . Shareholders whose email addresses are registered with the company, depositories, or depository participants as on the cut-off date will receive the notice electronically.

Source: None/Company/INE144Z01023/15cd636d-1314-4d48-9596-031e551d2016.pdf

Historical Stock Returns for Tarsons Products

1 Day5 Days1 Month6 Months1 Year5 Years
+8.06%+1.12%-5.72%-41.05%-49.22%-78.02%

More News on Tarsons Products

1 Year Returns:-49.22%